In addition to identifying upstream targets related to HIF1A and HIF2A, the proteomic data analysis predicted WISP2 (also referred to as CCN5) inhibition in ccRCC tissues. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.